Shortlysts
Topics
Medicare

Medicare

Tesla Shipping Covid Senate Gun control Hurricane South Korea Trump Canada China Hacking Gas Panama Canal FBI Radical Gender Ideology Elon Musk Venezuela Germany Abortion Commodities North Korea Lebanon California Green Energy Middle East Wages NPR Medicaid Harvard Florida Saudi Arabia Biotechnology U.S. Politics Congress Cyber Warfare Inflation Tech Public transit US Postal Service Oil Science Tsunami Energy Amazon Federal Reserve Europe New York City Medicine Louvre Ukraine Israel Banks DOGE Epstein Republican Party United Nations Military Supreme Court Mexico Charlie Kirk Health Syria Meta Pakistan India Housing Britain Voting Texas Marines Nobel Prize Drones Turkey H1B AI Earthquake Debt War Immigration Auto Industry Opioids Fentanyl Cryptocurrency DEI Steel ANTIFA Trade Unions Democratic Party Geopolitics Technology Tylenol RFK Jr Key Minerals Obamacare Poland Pop Culture Russia Education Second Amendment Property Gold United Kingdom NASA Donald Trump Moon Economy Robots Drone Bitcoin Jobs SEC USAID Terrorism Cambodia Aviation Transgender Nvidia Trudeau Government Putin Space U.K.Media Nuclear energy IRS Investment Tariffs Iran Police Joe Biden Crime OPEC CNN Wild Fires Pope DARPA Thailand Asia Greenland Australia FDA CIA Budget Facebook Illegal Aliens USA Treasury Social Security Google Medicare Japan Retail Censorship Floods Drugs Apple Super Bowl Interest Rates Department of Transport National Security Stocks Vaccine NATO TikTok

MedicareMedicare

+1+1

Inside AARP’s Quiet Campaign Against High Drug Prices

AARP’s long push to lower drug prices is reshaping Medicare rules, state policy, and the risks patients face at the pharmacy counter.

Tyler Flores

TrumpTrump

+2+2

President Trump Signs Executive Order Reclassifying Marijuana as Less Dangerous

President Trump removes marijuana from schedule one classification and reclassifies it as a less dangerous drug.

Jason Belcher

MedicineMedicine

+2+2

Fifteen Drugs, Billions in Savings: Medicare Lands Big Break for Taxpayers

Medicare’s new drug price agreements cut costs on high-spending medicines and establish a new approach to controlling the program’s rising expenses.

Tyler Flores

TrumpTrump

+2+2

Cutting the Tab: Trump Moves to Link U.S. Drug Prices to Lowest in the World

Trump plans to cut U.S. drug prices by tying them to the lowest prices globally, challenging Big Pharma and reshaping Medicare’s pricing model.

Tyler Flores